Kidney function may change how VC005 drug works
NCT ID NCT07551570
First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This early-stage study looks at how a single dose of VC005 tablets is processed in people with kidney impairment compared to those with normal kidney function. Researchers will measure drug levels in the blood and check safety. The goal is to understand if kidney problems affect how the drug behaves, which can guide future dosing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VC005 tablets
- What this could lead to
- If successful, this could help determine safe dosing of VC005 for people with kidney impairment.
- What could go wrong
- This is a very early Phase 1 study with only 32 people, so results may not apply broadly. It focuses on drug levels, not treatment effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Bengbu Medical University
RECRUITINGBengbu, Anhui, 233000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a damaged kidney change how antibiotics work?
- Can kidney health change how a new drug works?
- Kidney function may change how D-2570 works in the body
- Sleep drug YZJ-1139 put to the test in kidney patients
- Kidney function may change how antibiotic levornidazole acts in the body
- Kidney health may change how this drug works